This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Bonomi, Philip
| Item Type | Name |
|
Concept
|
Fluorouracil
|
|
Academic Article
|
Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment.
|
|
Academic Article
|
Concurrent chemotherapy and thoracic irradiation in non-small cell lung cancer.
|
|
Academic Article
|
Combined modality therapy for locally advanced non-small cell lung carcinoma.
|
|
Academic Article
|
Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy.
|
|
Academic Article
|
A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
|
|
Academic Article
|
Concomitant therapy with infusion of cisplatin and 5-fluorouracil plus radiation in stage III non-small cell lung cancer.
|
|
Academic Article
|
Phase II trial of therapy with etoposide, 5-fluorouracil by continuous infusion, cisplatin, and simultaneous split-course radiation in stage III non-small cell bronchogenic carcinoma.
|
|
Academic Article
|
Preoperative combined modality therapy for stage III M0 non-small cell lung carcinoma.
|
|
Academic Article
|
Simultaneous cisplatin fluorouracil infusion and radiation followed by surgical resection in regionally localized stage III, non-small cell lung cancer.
|
|
Academic Article
|
Phase II trial of etoposide, cisplatin, continuous infusion 5-fluorouracil, and simultaneous split-course radiation therapy in stage III non-small-cell bronchogenic carcinoma.
|
|
Academic Article
|
Inhibition of cancer cell proliferation by disruption of interdigitated/concatenated hierarchies of metabolic control/implementation processes: a proposal.
|
|
Academic Article
|
Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
|